Journal: Bone Research
Article Title: Human peripheral osteoclast-precursor-development patterns reveal the significance of RPS17-dependent ribosome synthesis to Ankylosing Spondylitis lesions
doi: 10.1038/s41413-025-00474-5
Figure Lengend Snippet: AS-associated monocytic evolution towards OCP-lineage fate. a Merged cell-trajectories of the above six subsets showing 5 cell-states and 2 cell-branches. State-1 is the starting point for differentiation. b Bubble plots showing the expression distribution of top genes belonging to various cell-states across five states. Circle size indicates percentage of cells expressing corresponding gene (PCT) and color depth indicates average expression levels. c GSVA scores in the osteoclastogenic functions between five states. Rows were normalized, and the transition of blue-white-red indicates an increase in the scores. d Heatmap showing relative intergroup comparisons of ACP5 , NFATC1 and OSCAR expression between five states. Rows were normalized, and the transition of blue-white-red indicates an increase in the gene expression. e PCT of ACP5 , NFATC1 and OSCAR across five states. f Immunofluorescence analysis of co-expression of MT-ND6, NAMPT and CSTA with OSCAR in CD14 + CD16 − monocytes. M + O + Cells/M + Cells represents the ratio of MT-ND6 and OSCAR-double-positive cells to MT-ND6-positive cells; N + O + Cells/N + Cells represents the ratio of NAMPT and OSCAR-double-positive cells to NAMPT-positive cells; C + O + Cells/C + Cells represents the ratio of CSTA and OSCAR-double-positive cells to CSTA-positive cells. g – i Flow cytometry of CD14 + CD16 − monocytes identifying the approximate trend of MT-ND6 + , NAMPT + and CSTA + cells at the 2nd, 4th, 8th and 16th hours of osteoclastic induction. j Proportions of five states from four groups. k Osteoclast differentiation capacities for CD14 + CD16 − monocytes of each three subjects from four groups. Scale bar: 100 µm. Data come from the mean values of osteoclasts in each three wells. l The expression distribution of MT-ND6, NAMPT, CSTA and CFD across four groups. Circle size indicates PCT and color depth indicates average levels. m Western-blotting analysis of MT-ND6, NAMPT, CSTA and CFD for CD14 + CD16 − monocytes from four groups of subjects ( n = 6/group; each 2 samples presented in one group). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.000 1 and ns (not significant) by one-way ANOVA
Article Snippet: After blockage with 5% milk, PVDFs were combined with antibodies targeting GAPDH (1:20 000, 10494-1-AP, Proteintech; IL, USA), TRAP (1:1 000, 11594-1-AP, Proteintech), CTSK (1:400, A1782, ABclonal; Wuhan, China), MMP9 (1:1 000, A0289, ABclonal), NFATC1 (1:1 000, A19597, ABclonal), CD14 (1:1 000, 17000-1-AP, Proteintech), S100A8 (1:1 000, 15792-1-AP, Proteintech), S100A9 (1:2 000, 26992-1-AP, Proteintech), S100A12 (1:1 000, A5328, ABclonal), RPLP1 (1:1 500, A6725, ABclonal), RPL13 (1:1 000, A9404, ABclonal), RPS12 (1:1 500, A5890, ABclonal), RPS28 (1:1 500, A17937, ABclonal), RPS17 (1:1 500, 16267-1-AP, Proteintech), MT-ND6 (1:2 000, A17991, ABclonal), NAMPT (1:2 000, A0256, ABclonal), CSTA (1:2 000, bsm-62286R, Bioss) and CFD (1:2 000, bs-13130R, Bioss) at 4 °C overnight.
Techniques: Expressing, Gene Expression, Immunofluorescence, Flow Cytometry, Western Blot